Optimization of rhodanine scaffold for the development of protein-protein interaction inhibitors

被引:5
|
作者
Ferro, Stefania [1 ]
De Luca, Laura [1 ]
Agharbaoui, Fatima Ezzahra [1 ]
Christ, Frauke [2 ,3 ]
Debyser, Zeger [2 ,3 ]
Gitto, Rosaria [1 ]
机构
[1] Univ Messina, Dipartimento Sci Farmaco & Prod Salute, I-98168 Messina, Italy
[2] Katholieke Univ Leuven, Mol Med, B-3000 Leuven, Flanders, Belgium
[3] IRC KULAK, B-3000 Leuven, Flanders, Belgium
关键词
Docking studies; Synthesis; Protein-protein interactions; Antiviral activity; HIV-1; INTEGRASE; MOLECULAR-MECHANICS; BINDING-SITE; LEDGF/P75; INSIGHT; DISCOVERY; ADHERENCE; DOCKING; DESIGN;
D O I
10.1016/j.bmc.2015.04.072
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Searching for novel protein-protein interactions inhibitors (PPIs) herein we describe the identification of a new series of rhodanine derivatives. The selection was performed by means virtual-screening, docking studies, Molecular Dynamic (MD) simulations and synthetic approaches. All the new obtained compounds were tested in order to evaluate their ability to inhibit the interaction between the HIV-1 integrase (IN) enzyme and the nuclear protein lens epithelium growth factor LEDGF/p75. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3208 / 3214
页数:7
相关论文
共 50 条
  • [1] Synthesis and biological evaluation of novel antiviral agents as protein-protein interaction inhibitors
    Ferro, Stefania
    De Luca, Laura
    Morreale, Francesca
    Christ, Frauke
    Debyser, Zeger
    Gitto, Rosaria
    Chimirri, Alba
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2014, 29 (02) : 237 - 242
  • [2] Protein-protein interaction inhibitors: advances in anticancer drug design
    Ferreira, Leonardo G.
    Oliva, Glaucius
    Andricopulo, Adriano D.
    EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (10) : 957 - 968
  • [3] Development of Protein-Protein Interaction Inhibitors for the Treatment of Infectious Diseases
    Voter, Andrew F.
    Keck, James L.
    PROTEIN-PROTEIN INTERACTIONS IN HUMAN DISEASE, PT B, 2018, 111 : 197 - 222
  • [4] Rational Design, Synthesis and Evaluation of Coumarin Derivatives as Protein-protein Interaction Inhibitors
    De Luca, Laura
    Agharbaoui, Fatima E.
    Gitto, Rosaria
    Buemi, Maria Rosa
    Christ, Frauke
    Debyser, Zeger
    Ferro, Stefania
    MOLECULAR INFORMATICS, 2016, 35 (8-9) : 460 - 473
  • [5] A Leap into the Chemical Space of Protein-Protein Interaction Inhibitors
    Villoutreix, B. O.
    Labbe, C. M.
    Lagorce, D.
    Laconde, G.
    Sperandio, O.
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (30) : 4648 - 4667
  • [6] Rational design of protein-protein interaction inhibitors
    Rognan, Didier
    MEDCHEMCOMM, 2015, 6 (01) : 51 - 60
  • [7] Non-Peptidic α-Helical Mimetics as Protein-Protein Interaction Inhibitors
    Dewal, M. B.
    Firestine, S. M.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (16) : 2420 - 2428
  • [8] Discovery of novel inhibitors of LEDGF/p75-IN protein-protein interactions
    Sanchez, Tino Wilson
    Debnath, Bikash
    Christ, Frauke
    Otake, Hiroyuki
    Debyser, Zeger
    Neamati, Nouri
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (04) : 957 - 963
  • [9] Optimization of Peptidomimetics as Selective Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction
    Wang, Zhen
    Zhang, Min
    Wang, Jin
    Ji, Haitao
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (07) : 3617 - 3635
  • [10] Identification of Protein Interaction Partners and Protein-Protein Interaction Sites
    Sacquin-Mora, Sophie
    Carbone, Alessandra
    Lavery, Richard
    JOURNAL OF MOLECULAR BIOLOGY, 2008, 382 (05) : 1276 - 1289